These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 22381901)

  • 1. Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of melanoma xenografts.
    Ovrebø KM; Ellingsen C; Galappathi K; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e121-7. PubMed ID: 22381901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of tumor radioresponsiveness and metastatic potential by dynamic contrast-enhanced magnetic resonance imaging.
    Øvrebø KM; Gulliksrud K; Mathiesen B; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):255-61. PubMed ID: 21816291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of tumors: a preclinical study of cervical carcinoma and melanoma xenografts.
    Øvrebø KM; Ellingsen C; Hompland T; Rofstad EK
    Acta Oncol; 2013 Apr; 52(3):604-11. PubMed ID: 22671573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of hypoxia in human cervical carcinoma xenografts by dynamic contrast-enhanced magnetic resonance imaging.
    Ellingsen C; Egeland TA; Gulliksrud K; Gaustad JV; Mathiesen B; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):838-45. PubMed ID: 19215820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic contrast-enhanced-MRI of tumor hypoxia.
    Egeland TA; Gulliksrud K; Gaustad JV; Mathiesen B; Rofstad EK
    Magn Reson Med; 2012 Feb; 67(2):519-30. PubMed ID: 21661044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic contrast-enhanced magnetic resonance imaging of human melanoma xenografts with necrotic regions.
    Gaustad JV; Benjaminsen IC; Ruud EB; Rofstad EK
    J Magn Reson Imaging; 2007 Jul; 26(1):133-43. PubMed ID: 17659570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of extravascular extracellular space fraction in human melanoma xenografts by DCE-MRI and kinetic modeling.
    Benjaminsen IC; Brurberg KG; Ruud EB; Rofstad EK
    Magn Reson Imaging; 2008 Feb; 26(2):160-70. PubMed ID: 17692490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the interstitial fluid pressure of tumors by dynamic contrast-enhanced magnetic resonance imaging with contrast agents of different molecular weights.
    Hompland T; Gulliksrud K; Ellingsen C; Rofstad EK
    Acta Oncol; 2013 Apr; 52(3):627-35. PubMed ID: 23126523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitations of dynamic contrast-enhanced MRI in monitoring radiation-induced changes in the fraction of radiobiologically hypoxic cells in human melanoma xenografts.
    Benjaminsen IC; Melås EA; Mathiesen BS; Rofstad EK
    J Magn Reson Imaging; 2008 Nov; 28(5):1209-18. PubMed ID: 18972344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of tumor blood perfusion assessed by dynamic contrast-enhanced MRI with tumor blood supply assessed by invasive imaging.
    Graff BA; Benjaminsen IC; Brurberg KG; Ruud EB; Rofstad EK
    J Magn Reson Imaging; 2005 Mar; 21(3):272-81. PubMed ID: 15723369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic contrast-enhanced magnetic resonance imaging of tumor interstitial fluid pressure.
    Gulliksrud K; Brurberg KG; Rofstad EK
    Radiother Oncol; 2009 Apr; 91(1):107-13. PubMed ID: 18973959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic contrast-enhanced magnetic resonance imaging of tumors: preclinical validation of parametric images.
    Egeland TA; Simonsen TG; Gaustad JV; Gulliksrud K; Ellingsen C; Rofstad EK
    Radiat Res; 2009 Sep; 172(3):339-47. PubMed ID: 19708783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DCE-MRI of the hypoxic fraction, radioresponsiveness, and metastatic propensity of cervical carcinoma xenografts.
    Ellingsen C; Hompland T; Galappathi K; Mathiesen B; Rofstad EK
    Radiother Oncol; 2014 Feb; 110(2):335-41. PubMed ID: 24231244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumor heterogeneity in blood perfusion in orthotopic human melanoma xenografts assessed by dynamic contrast-enhanced magnetic resonance imaging.
    Gaustad JV; Benjaminsen IC; Graff BA; Brurberg KG; Ruud EB; Rofstad EK
    J Magn Reson Imaging; 2005 Jun; 21(6):792-800. PubMed ID: 15906326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation between hypoxic and non-hypoxic experimental tumors by dynamic contrast-enhanced magnetic resonance imaging.
    Gulliksrud K; Øvrebø KM; Mathiesen B; Rofstad EK
    Radiother Oncol; 2011 Mar; 98(3):360-4. PubMed ID: 21262548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of fraction of radiobiologically hypoxic cells in human melanoma xenografts by dynamic contrast-enhanced MRI.
    Egeland TA; Gaustad JV; Vestvik IK; Benjaminsen IC; Mathiesen B; Rofstad EK
    Magn Reson Med; 2006 Apr; 55(4):874-82. PubMed ID: 16506163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial fluid pressure and associated lymph node metastasis revealed in tumors by dynamic contrast-enhanced MRI.
    Hompland T; Ellingsen C; Øvrebø KM; Rofstad EK
    Cancer Res; 2012 Oct; 72(19):4899-908. PubMed ID: 23027087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in intratumor heterogeneity in blood perfusion in intradermal human melanoma xenografts during tumor growth assessed by DCE-MRI.
    Graff BA; Benjaminsen IC; Melås EA; Brurberg KG; Rofstad EK
    Magn Reson Imaging; 2005 Nov; 23(9):961-6. PubMed ID: 16310112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of tumor blood perfusion by high-resolution dynamic contrast-enhanced MRI: a preclinical study of human melanoma xenografts.
    Benjaminsen IC; Graff BA; Brurberg KG; Rofstad EK
    Magn Reson Med; 2004 Aug; 52(2):269-76. PubMed ID: 15282808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tumor bed effect: increased metastatic dissemination from hypoxia-induced up-regulation of metastasis-promoting gene products.
    Rofstad EK; Mathiesen B; Henriksen K; Kindem K; Galappathi K
    Cancer Res; 2005 Mar; 65(6):2387-96. PubMed ID: 15781654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.